Zepbound side effects at a glance
| Symptom | % of patients | When peaks | When resolves |
|---|---|---|---|
| Nausea | ~31% | Day 2-5 post-dose | Day 7-10 |
| Diarrhea | ~23% | Day 1-3 post-dose | Day 5-7 |
| Constipation | ~18% | Day 4-10 post-dose | Variable (manage with hydration) |
| Vomiting | ~14% | Day 2-5 post-dose | Day 7 |
| Fatigue | ~5-8% | Day 2-7 post-dose | Week 4-6 (dose-stable) |
| Injection site reaction | ~8% | Day 1 post-injection | Day 2-4 |
Week 1: First injection (2.5mg starting dose)
The first week on Zepbound is typically the most challenging. Your body has never experienced GLP-1/GIP receptor activation at this level, and the first dose triggers the fullest GI response.
- Day 1-2: Mild fatigue, possibly mild nausea starting
- Day 3-5: Peak nausea for most patients. Some experience vomiting (typically 1-2 episodes, not persistent). Diarrhea or constipation depending on individual response.
- Day 6-7: Symptoms taper; appetite suppression is now the dominant effect. Fatigue may persist.
Most clinicians advise small frequent meals, bland foods (BRAT diet — bananas, rice, applesauce, toast), aggressive hydration, and electrolyte replacement during week 1. Severe vomiting preventing fluid intake warrants a call to your prescriber.
Weeks 2-4: Adjustment phase on starting dose
By week 2, most patients have adjusted to the 2.5mg starting dose. Side effects significantly diminish or resolve. Appetite suppression, modest weight loss, and improved glycemic patterns become the dominant experience.
The 2.5mg dose is intentionally subtherapeutic — designed as a runway to the higher doses where significant weight loss occurs. Most patients tolerate weeks 2-4 with minimal symptoms beyond mild residual fatigue.
Week 5: Dose increase to 5mg
The standard Zepbound titration moves to 5mg at week 5. This dose increase produces a smaller but real spike in side effects — typically less intense than the initial week because the body has already adjusted to GLP-1/GIP receptor activation.
Expect 3-5 days of moderate nausea (less severe than week 1), possibly mild GI symptoms. Most patients report week 5 as significantly easier than week 1. Patients who struggle with the 5mg jump can sometimes negotiate a slower titration (extended 2.5mg for 8 weeks, then move to 5mg) with their prescriber.
Subsequent dose increases (7.5mg, 10mg, 12.5mg, 15mg)
The standard titration adds a dose level every 4 weeks: 7.5mg at week 9, 10mg at week 13, 12.5mg at week 17, 15mg at week 21 if needed for full therapeutic effect. Each increase produces a smaller spike in side effects than the previous one.
The maximum effective dose for most patients is 10mg or 15mg. Some patients achieve their weight-loss goals at 5mg or 7.5mg and don't need to titrate further. Dose decisions are individualized based on tolerability and response.
When side effects warrant calling your doctor
Call immediately for:
- Severe persistent abdominal pain — pancreatitis red flag (rare but documented with GLP-1 medications)
- Persistent vomiting preventing fluid intake — dehydration risk requires intervention
- Yellowing of skin or eyes — gallbladder or liver involvement
- Severe injection-site reactions — signs of infection, large rashes, swelling
- Vision changes — rare but documented complication
- Allergic reaction signs — hives, difficulty breathing, throat swelling
- Suicidal thoughts or severe depression — FDA monitoring includes mental health adverse events
For routine titration nausea, constipation, or mild fatigue, follow your prescriber's standard guidance (hydration, fiber, antacids, electrolyte replacement). Routine symptoms don't typically require a clinical visit but should be reported at your next scheduled check-in.
Practical management tips for routine side effects
- Nausea: Small frequent meals (4-6 small meals vs 3 large), bland foods, ginger, peppermint tea, OTC antiemetics if approved by your prescriber
- Constipation: Aggressive hydration (3+ liters/day), fiber supplement, magnesium citrate or polyethylene glycol (Miralax) as needed
- Diarrhea: BRAT diet, electrolyte replacement (Liquid IV, Pedialyte), avoid dairy and high-fat foods temporarily
- Fatigue: Adjust meal timing, ensure adequate protein intake (40+g per meal), check ferritin and B12 levels at next labs
- Injection-site reactions: Rotate injection sites, ensure proper technique (clean site, slow injection), warm compress for soreness
FAQ
How long do Zepbound side effects last?
Most common side effects (nausea, fatigue, constipation) peak in week 1-2 after each dose increase and resolve within 4-6 weeks as your body adjusts. Patients on a stable maintenance dose typically experience minimal ongoing side effects after the titration period. Severe side effects (pancreatitis, gallbladder disease, severe nausea/vomiting requiring hospitalization) are rare but require immediate medical attention rather than wait-and-see.
What are the most common Zepbound side effects?
Per Zepbound's FDA labeling and post-market data: nausea (most common — 31% of patients in trials), diarrhea (23%), constipation (18%), vomiting (14%), fatigue (5-8%), abdominal pain (10%), injection-site reactions (8%). Most resolve within the first few weeks of each dose level. Severe and persistent symptoms warrant clinical follow-up.
When do Zepbound side effects start?
Within 24-72 hours of the first injection at each new dose level. The first injection (2.5mg starting dose) often produces mild nausea and fatigue starting day 2-3 post-injection. Symptoms typically peak day 3-5 and taper through day 7. Each subsequent dose increase (5mg, 7.5mg, 10mg, 12.5mg, 15mg) produces a similar but typically diminishing pattern.
Will Zepbound side effects go away?
For most patients, yes — within 4-6 weeks of reaching a stable maintenance dose, the day-to-day side effect burden is minimal. The pattern is: significant side effects during dose titration, then progressive improvement as the body adjusts. Patients who stay on the same dose for 8+ weeks rarely report ongoing significant nausea or fatigue.
What's the worst week on Zepbound?
Most patients report week 1 after the first injection (2.5mg dose) as the most challenging — the body's initial adjustment to GLP-1 receptor activation. After that, each dose increase produces a brief spike in side effects that's typically less intense than the initial week. The 'worst week' for any individual patient depends on which dose level produces the strongest GI response.
Are Zepbound side effects worse than Wegovy?
Marginally different but clinically similar. Tirzepatide (Zepbound) acts on both GIP and GLP-1 receptors; semaglutide (Wegovy) only on GLP-1. Some patients tolerate one better than the other. Head-to-head data from the SURMOUNT trials shows comparable side-effect profiles with slight differences in nausea distribution. Switching between them when one is poorly tolerated is reasonable clinical practice.
What side effects warrant calling my doctor?
Call immediately for: severe abdominal pain that doesn't resolve (pancreatitis red flag), persistent vomiting preventing fluid intake (dehydration risk), yellowing of skin or eyes (gallbladder/liver red flag), severe injection-site reactions (rash, swelling, signs of infection), vision changes (rare but documented), allergic reactions (hives, difficulty breathing). For routine titration nausea/constipation, follow your prescriber's standard guidance.
Bottom line on Zepbound side effects
Most Zepbound side effects are GI-related, peak within the first week of each dose increase, and resolve within 4-6 weeks as your body adjusts. Severe persistent symptoms warrant immediate clinical follow-up. The pattern improves dramatically once you reach a stable maintenance dose.
Find a GLP-1 program that fits →